Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Intralesional Antimony for Bolivian Cutaneous Leishmaniasis

This study has been completed.
The Alfred Berman Foundation for Medical Research
Universidad Mayor de San Simón
Hospital Dermatológico de Jorochito
Proyecto OSCAR
Information provided by (Responsible Party):
Fundacion Nacional de Dermatologia Identifier:
First received: February 17, 2011
Last updated: July 3, 2012
Last verified: July 2012